罕见遗传疾病中的药物治疗风险:交叉引用ACMG二次发现 v3.2 与临床数据库列表
Josiah D Allen1, Benjamin Q Duong2, Jordan Brady1
1Department of Precision Medicine and Genomic Health, St. Elizabeth Healthcare, Edgewood, Kentucky, USA.
Clinical and translational science
|January 13, 2026
概括
临床基因组学和药物基因组学在基因表型影响方面有显著的重叠. 鉴定这些联系对于患者安全和有效的药物使用至关重要,因为基因测试正在扩大.
科学领域:
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
- 医疗信息学 医疗信息学
背景情况:
- 临床基因组学和药物基因组学是不同的领域.
- 与疾病和药物影响重叠的遗传变异被研究不足.
- 整合这些领域对于全面的患者护理至关重要.
研究的目的:
- 识别和分类具有重叠的临床基因组学和药物基因组学影响的基因-表型对.
- 评估遗传变异和药物反应之间的重叠程度.
- 突出未知药物影响的潜在患者安全风险.
主要方法:
- 交叉引用美国医学遗传学学院二级发现 v3.2 基因与基因组数据库和药物标签.
- 在GeneReviews,ClinPGx和FDA标签数据库中搜索了基因-表型对.
- 经过PGx培训的药剂师和遗传咨询师根据药疗影响分类基因表型对成三级.
主要成果:
- 审查了97个基因-表型对.
- 23% (一级) 有FDA/指南建议.
- 32% (第二级) 显示了潜在的药物治疗影响.
- 45% (3级) 没有/有弱相互作用.
- 从直接的疾病病理和不那么明显的关联中确定了药物治疗风险.
结论:
- 很大一部分基因-表型对具有药物基因组学意义.
- 不被认可的药物含义可能会给患者带来安全风险.
- 多学科合作和信息传播对于整合临床基因组学和药物基因组学至关重要.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Therapeutic Drug Monitoring: Overview and Classification
304
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
304
Therapeutic Drug Monitoring: Affecting Factors
196
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
196
Genetic Screens
5.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
397
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
397
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
179
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
179


